|
|
MONDAY AUGUST 27
Icahn’s Biotech Play Never too proud to learn from a master, Trader Daily is watching closely as Icahn, a former student of medicine, scampers for shares of what he sees as undervalued biotech companies. His latest purchase? A $146.59-million stake in industry stalwart, Biogen. August 2007New User?Sign up to get free access to TraderDaily.com
|
|